Category: HPB & Spleen

Combined Hepatocholangiocarcinoma: Worse Survival Than Hepatocellular Carcinoma, Similar to Intrahepatic Cholangiocarcinoma

In a retrospective study of 3,196 surgery-treated patients with combined hepatocholangiocarcinoma, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, survival outcomes were analyzed. Despite data limitations, overall survival for combined hepatocholangiocarcinoma was worse than hepatocellular carcinoma but similar to intrahepatic cholangiocarcinoma. Disease-free survival was comparable among the three groups. Predictors of mortality included the cancer subtype, metabolic syndrome, […]

US Hepatopancreatobiliary Surgeon Supply Surpasses Demand

Examining 1998-2019 data, this study unveils a potential surplus in the supply of hepatopancreatobiliary (HPB) surgeons in the US. In 2019, 37,335 inpatient HPB procedures occurred, with an estimated 905-1191 practicing HPB surgeons. Factoring in centralization and volume-outcome benchmarks, the study projects a possible oversupply by 2030. Without adjustments, the data suggests a risk of […]

Laparoscopic Liver Tunnel for Hepatocaval Confluence Tumors

Researchers present a groundbreaking laparoscopic liver tunnel technique for tumors at the hepatocaval confluence, expanding parenchyma-sparing surgery possibilities. A case study involving synchronous colorectal liver metastases demonstrates the feasibility of this approach, allowing resection of ill-located tumors with complex vascular relationships through minimally invasive means. The method significantly enhances the scope of liver surgery, particularly […]

Pancreatic Adenocarcinoma: ASO Guidelines on Surgical and Multimodal Management

Addressing the aggressive nature of pancreatic adenocarcinoma, this study outlines ASO practice guidelines for surgical and multimodal management. Focusing on resectable, borderline resectable, and locally advanced cases, the guidelines aim to equip surgical oncologists with current recommendations. By delving into the supporting data, the study provides a comprehensive framework for effectively managing pancreatic adenocarcinoma, emphasizing […]

Neoadjuvant Therapy Impact on Pancreatic Cancer: Fibrotic Response Variation and Survival Associations

Examining pancreatic ductal adenocarcinoma (PDAC) cases (1991-2020) with neoadjuvant treatment (NAT), this study categorizes fibrotic responses and explores their links to different NAT strategies (chemotherapy, chemoradiation, or total neoadjuvant therapy, TNT). Major fibrosis, most prevalent in TNT cases, correlates with superior outcomes, including higher rates of downstaging, complete responses, favorable margins, and improved overall and […]

Laparoscopic vs. Open Pancreatoduodenectomy in Long-Term OS Battle

In the clash of surgical titans for pancreatic or periampullary tumors, laparoscopic and open approaches square off. The 3-year showdown reveals no knockout punches. Among the contenders, laparoscopic pancreaticoduodenectomy (LPD) doesn’t outshine open PD in the ring of overall survival (OS). Both LPD and open PD go the distance with a similar 3-year OS, showcasing […]

Innovative Maneuvers in Laparoscopic Spleen-Preserving Distal Pancreatectomy: The Gastrohepatic Ligament Approach

Surgeons pioneering laparoscopic spleen-preserving distal pancreatectomy (lspdp) embraced the gastrohepatic ligament approach, deftly navigating preservation of splenic vessels. With a concise operation time of 186 minutes and minimal blood loss (37 ml), their approach, showcased in a video, emerges as a strategic option for low-grade malignant tumors. This professional journey promises smoother seas for lspdp, […]

Snap, Scan, Predict: CT Measurements Forecast Pancreatic Fistula Risk After Pancreatoduodenectomy

In the realm of pancreatoduodenectomy, a study unfolds a CT-based crystal ball. Researchers spot predictive markers—pancreatic neck thickness (>1.3 cm), intra-abdominal distance (>5.8 cm), soft pancreas, and narrow duct—signaling heightened risk of postoperative pancreatic fistula. Notably, abdominal wall thickness and obesity play no role. This snapshot tool not only forecasts complications but introduces a potential […]

Mapping the Road: Lymph Node Metastasis Spells Prognostic Challenge in Nonfunctioning Pancreatic Neuroendocrine Neoplasms

For those tackling nonfunctioning pancreatic neuroendocrine neoplasms (NFPanNENs), the question was: How much lymph node removal is the sweet spot? This study dug into 84 patients’ data, revealing that lymph node metastasis near the tumor was the key player in predicting a tough road ahead. Pancreatic head tumors saw trouble at stations 8, 13, and […]

Impact and Strategies for Unplanned Conversions in Robotic Pancreaticoduodenectomy

In the robotic frontier of pancreaticoduodenectomy, a study of 400 patients revealed a 10.5% unplanned conversion rate. Men, especially, faced this detour, often due to vascular surprises or bleeding challenges. While conversions meant shorter surgeries, they spiked blood loss and complications, with higher mortality rates. Thankfully, conversion rates decreased over time, suggesting growing surgeon proficiency. […]